As cell proliferation was significantly reduced by dCas9 targeting the OCT4-binding site in both MYCN-amplified NB cell lines (Figure 1D), we investigated the effect of inhibition of the OCT4-binding site on MYCN activity. The gene discussed is MYCN; the disease is neuroblastoma.